| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |